Friedreich's Ataxia

Friedreich's ataxia is a rare autosomal recessive disease caused by defects in FXN gene and characterized by progressive damage of the nervous system and movement problems. Here is the latest research.

February 20, 2020
Review

Nosology and Phenomenology of Psychosis in Movement Disorders

Movement Disorders Clinical Practice
Malco RossiMarcelo Merello
April 16, 2020
Open Access

A Comprehensive Transcriptome Analysis Identifies FXN and BDNF as Novel Targets of miRNAs in Friedreich's Ataxia Patients

Molecular Neurobiology
Julia O MisiorekMarek Napierala
July 1, 2020

Hereditary spastic paraplegia type 11 (SPG11) is associated with obesity and hypothalamic damage

Journal of the Neurological Sciences
Ana Luisa de Carvalho Cardozo-HernándezMarcondes Cavalcante França
April 28, 2020

Neurologic outcomes in Friedreich ataxia: Study of a single-site cohort

Neurology. Genetics
Massimo Pandolfo
March 11, 2020
Open Access

Reply: The repeat variant in MSH3 is not a genetic modifier for spinocerebellar ataxia type 3 and Friedreich's ataxia

Brain : a Journal of Neurology
Michael FlowerDarren G Monckton
April 29, 2020
Review

Therapeutic potential of stem cells for treatment of neurodegenerative diseases

Biotechnology Letters
Hamid Ahmadian-MoghadamMohammad-Reza Zarrindast
February 28, 2020
Open Access

Epigenetic regulation of clinical manifestations of Friedreich's disease

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
E P NuzhnyE Yu Fedotova
June 26, 2020
Open Access

HMTase Inhibitors as a Potential Epigenetic-Based Therapeutic Approach for Friedreich's Ataxia

Frontiers in Genetics
Mursal SherzaiSara Anjomani Virmouni
February 27, 2020
Review
Open Access

Management of Neuroinflammatory Responses to AAV-Mediated Gene Therapies for Neurodegenerative Diseases

Brain Sciences
Barbara A PerezManuela Corti
May 10, 2020

Neurofilament light chain as a potential biomarker of disease status in Friedreich ataxia

Journal of Neurology
Alexandra ClayDavid R Lynch
February 12, 2020
Open Access

Psychometric properties of the Friedreich Ataxia Rating Scale

Neurology. Genetics
Christian RummeyDavid R Lynch
April 1, 2020
Preprint
Open Access

High levels of frataxin overexpression leads to mitochondrial and cardiac toxicity in mouse models

BioRxiv : the Preprint Server for Biology
Brahim BelbellaaHelene Puccio

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

4H Leukodystrophy

4H Lekodystrophy involves hypomyelination, hypogonadotropic hypogonadism and hypodontia. It is also known as POLR-3Related Leukodystrophy. 4H syndrome symptoms include delayed or abnormal puberty, issues with central nervous system signal transmission, abnormal development of teeth, and symptoms tend to progressively get worse over time. There is not yet a known cure.

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

© 2020 Meta ULC. All rights reserved
/feed-previews/friedreichs-ataxia/c30e5a68-e9cf-4a04-b0cf-19c425642743